Apostolos Karantanas was born in Larissa, Greece. He graduated the Medical School, University of Ioannina, Greece at 1983. Dr. Karantanas completed the Radiology training in University Ηospital of Ioannina. He undertook musculoskeletal training on metabolic bone disorders in New York University Medical Center and on MR imaging MSK applications in Manchester Medical School/Manchester Royal Infirmary. He has been given 370 invited lectures in 27 countries and is a regular faculty member in ECR, ISS, Erasmus courses MSK MRI, School of MRI/ESMRMB, ESOR and ESSR. He is the author of 171 Medline/188 Scopus publications (h index 24, citations 2100; Google Scholar citations: 3.450, h index:33, i10 index:82), 6 books, 57 chapters in books and 345 announcements in international conferences. Prof. Karantanas is a reviewer in 21 Medline journals, Editorial Board in two and has been a Guest Editor in 3 issues of medline journals. He has been Visiting Professor at the Universities of Leeds and Amsterdam. Prof. Karantanas is currently Professor of Radiology - University of Crete, Chairman of the Department of Medical Imaging and Director of the Laboratory Section - Heraklion University Hospital, Member of the ESOR Programme Planning Committee, Member of the Educational Committee of the European Society of Radiology, Member of the Sports Injuries Subcommittee/ESSR, Affiliated Scientist to the FORTH-institute, General Secretary of the Hellenic College of Radiology, Honorary President of the Radiological Society of Crete, and President of the Hellenic Society of Musculoskeletal Radiology.

His main research is focused on imaging of musculoskeletal disorders including bone marrow, osteoporosis, sports injuries, osteoarthritis, hip joint and applications of newer MR sequences and advanced models of data analysis in perfusion and diffusion imaging. He is past President of European Society of Musculoskeletal Radiology and past member of the Educational Committee of the European Association of Radiology.

Professor Sanjay Gandhi is a senior attending radiologist at one of the largest teaching hospitals and regional trauma units in the UK. For the past 17 years, he has been teaching the University of Bristol and University of West of England trainees. As Honorary Professor he also teaches at Sri Devaraj Urs University, India. He has won multiple academic awards and has been involved in numerous research projects and collaborative trials. Professor Gandhi has published widely on use cutting-edge technology and co-authored and edited eight medical textbooks. He is an internationally recognized leader in HealthcareIT and development of smart Apps.

Dr. Habib Zaidi is senior physicist and head of the PET Instrumentation & Neuroimaging Laboratory at Geneva University Hospital. He received a Ph.D. in medical physics from GenevaUniversity for a dissertation on Monte Carlo modelling and scatter correction in positron emission tomography. His academic accomplishments in the area of quantitative PET imaging have been well recognized by the Medical School of Geneva University, which elected him to become faculty member as Privat-Docent. Dr. Zaidi is actively involved in developing imaging solutions for cutting-edge biomedical research and clinical diagnosis in addition to lecturing graduate and postgraduate courses on medical physics and medical imaging. His research centre on modelling nuclear medical imaging systems using the Monte Carlo method, dosimetry, image correction, reconstruction and quantification techniques in emission tomography as well as statistical image analysis in functional brain imaging, and more recently on novel design of dedicated high-resolution PET scanners in collaboration within the Computed Imaging for Medical Applications (CIMA) collaboration hosted by CERN.

Bin Zheng received his PhD from University of Delaware in 1993. After working in Department of Radiology, University of Pittsburgh for 20 years, he joined faculty in University of Oklahoma in 2013 as a Professor at School of Electrical and Computer Engieering and Oklahoma TSET cancer research scholar at Stephensn Cancer Center. Since 1998, he has served as PI in five R01 and one R21 grant awards from NCI, NIH, one DOD breast cancer project, and subcontract PI of two other NIH R01 grant awards. Currently, he is AIMBE fellow and an editor-in-chief of Journal of X-ray Science and Technology.

Norio Tagawa received the M.E. degree from Tokyo Institute of Technology in 1989 and the D.E. degree from Tokyo Metropolitan University in 1995. He joined Fujitsu Laboratories Ltd. in 1989, and now a Professor in the Graduate School of System Design, Tokyo Metropolitan University. His research interests are in computational vision and medical ultrasound. engineering.

Giovanni Morana graduated at Medical School in 1986; in 1992 he completed the Radiological Residency at the University of Verona. From october 1988 to september 2004 he has been a Clinical Staff Member in the Department of Radiology of the University of Verona. From September 2004 he is Chief of the Radiological Department of the Treviso General Hospital. He was habilitated for full Professorship in Radiology in 2014. He has published 60 papers, 25 chapters of book, 82 abstracts and 36 posters. His posters have been prized in several international meetings. He has been given more than 250 lectures either in national and international meetings.

He has been organized several meetings mainly focused on body MR and Gastro-intestinal imaging.

Professor Kattesh V. Katti is internationally recognized as a leader in the interconnecting fields of—chemistry, radiopharmaceutical sciences, nanotechnology/green nanotechnology and nanomedicine—for biomedical applications, specifically for molecular imaging and therapy of living subjects. Dr. Katti has been awarded a number of international awards and citations which include: Winner of the 2016 'Person of the Year in Science' award by Vijayavani, India's most influential newspaper with over 75 million readership base. Dr. Katti has been selected for this coveted award for his pioneering research to connect India's 5000 year old traditional holistic medicine (Ayurveda) with scientifically sound nanomedicine through his ingenious green nanotechnology research. This work has created a new field of holistic medicine which Dr. Katti refers to as nano-ayurvedic medicine. International Hevesy Medal Award (2015) for excellence in Nuclear Sciences; Elected to the fellowship of the National Academy of Inventors (2015) recognizing the discovery of ‘Katti Peptides’; One of the ‘25 Most Influential Scientists In Molecular Imaging in the World’ award by RT Image, the ‘Father of Green Nanotechnology’ citation by the Nobel Prize Winner Norman Borlaug, Gauss Professorship—Hall of Fame—from the Gottingen Academy of Sciences, ‘Outstanding Scientists Fellows’ award and induction as a Fellow of the Academy of Science, St Louis—one of the oldest scientific academies of the world and many more. In 2013, Dr. Katti was elected as a fellow of the American Association for the Advancement of Science with a citation “for distinguished contributions encompassing nanoscale chemistry, particularly for ground breaking discoveries enabling application of nanotechnology concepts for biomedical applications”. His unprecedented discovery of the production of tumor specific gold nanoparticles through 100% green processes have been cited as the Editor’s choice in Nature, Future Medicine, in Science (AAAS), in Popular Science, by the Discovery Channel and have been highlighted in scientific/medical programs of the British Broadcasting Corporation (BBC, London).

Nanoscience, Nanotechnology and Green Nanotechnology in Nanomedicine, Innovations in Green Nanotechnology, Radiopharmaceutical Sciences in molecular imaging and therapy, Metals/Organometallics In the Development of Cancer Diagnostic and Therapeutic Agents ,Biomedical Optical Imaging

Bin Zhu is the director of the department of Radiology, Affiliated Drum Tower Hospital, Nanjing University School of Medicine. He has published more than 30 papers in reputed journals and has been serving as an editorial board member of repute.

Dr. Hesham El Sheikh, Medicine doctor (MD- Medicine), now is a Professor of Radiology. He got his BSc in medicine, MSc in Radiology, MD degree at Benha University, Egypt. Dr: Hesham is an old friend as a speaker for word cancer congress (WCC) that usually held in China. He has published more than 21 papers in reputed journals

Dr. Hesham El Sheikh researches focus on identification of sonographic and mammographic features of intraductal breast masses that may be associated with malignancy.

Professor Cho received Ph.D, in physics, from Univ. of Uppsala, Sweden in Physics. Since then he has been faculty of UCLA, Columbia University, and University of California, Irvine. Last ten years, he served as a Director of the Neuroscience Research Institute, Gachon University and established one of the leading PET-MRI brain imaging centers in the world. Professor Cho is an early pioneer of CT and PET, developing world’s first circular ring PET (at UCLA, 1975) and BGO (PET-detector, 1976) and more recently 7.0T MRI+PET Fusion Brain Imaging System at NRI, in Korea. Currently Professor Cho is serving as a Distinguished Research Fellow at Seoul National University, Seoul, Korea, and also as a member of National Academy of Medicine, Washington D.C. USA. He has 334 publications & 5695 citations.

Dr. Zweit is a professor of Radiology, and affiliate professor of Radiation Oncology, Pathology, Biochemistry & Molecular Biology and Chemistry at Virginia Commonwealth University (VCU). He is also the Director of the Center for Molecular Imaging at VCU School of Medicine. He leads an inter-disciplinary and inter-collaborative molecular imaging research program that emphasizes multi-modality approaches to study biochemical and biological pathways in vivo. Professor Zweit’s research interests include the development of paradigms for molecular imaging and nanotechnology strategies for preclinical and clinical translational research in cancer biology and therapeutics. He is internationally recognized for his work in molecular imaging of cancer drug development, and conducted the “world’s first” Molecular PET Imaging clinical trial of Anti-angiogenic therapy in cancer patients (Journal National Cancer Institute 2002). Professor Zweit serves as an advisor on a number of committees, including the Cancer Research UK Pharmacodynamic and Pharmacokinetic Technologies Advisory Committee (Journal National Cancer Institute, 2006). He serves on the review body of a number of funding organizations, both in Europe and North America. He has supervised a total of 24 MSc, MD and PhD theses. He has published more than 100 peer reviewed articles, over 250 conference abstracts, and 6 review articles and book chapters. Professor Zweit obtained his PhD and DSc from the University of Manchester Medical School. Prior to that, He studied for an MSc degree in PET Pharmacology. He received his Nuclear Medicine training at the John F. Kennedy Medical Centre in New Jersey, and attended advanced Nuclear Medicine training at the Brooklyn Hospital in New York. As an Undergraduate, he obtained his Bachelor of Science degree, in Radiation Biophysics, with a Biochemistry double major, from the University of Kansas.

Multi-modality molecular and cellular imaging. Biologically targeted probe development and ulti-probe pre-clinical imaging. Nano-particle and quantum dot molecular and cellular imaging. Translational clinical molecular imaging in drug development. Pharmacokinetics and pharmacodynamics studies in oncology and neuroscience.

Faiq Shaikh received the M.B.,B.S. degree (2006) from Liaquat University of Medical & Health Sciences, Pakistan. He was a postdoctoral research fellow in Cancer Imaging at the University of North Carolina Chapel Hill (2007-2009). His post-graduate clinical training includes Surgery Internship at Montefiore Medical Center (2009-2010), nuclear medicine residency at University of North Carolina Chapel Hill (2010-2013), Positron Emission Tomography Fellowship at University of Iowa (2014-2015) and an Imaging Informatics fellowship at University of Pittsburgh Medical Center (2015-). He has a book chapter and 17 publications in the fields of Nuclear therapeutics, Cancer Imaging, Genetic/Molecular Imaging and Imaging Informatics. He is an editor and reviewer of multiple scientific journal and is the CEO of a biotechnology startup focusing on educational informatics.

Dr. Veith graduated from Cornell and completed his residency at the Brigham and Harvard. In the 1970s and 1980s, he performed pioneering work in lung transplantation while his clinical interest involved Vascular Surgery focusing on limb revascularizations and an aggressive approach to saving threatened limbs when most patients with this problem underwent amputation. In the late 1980s, Dr. Veith became involved with endovascular treatments. His group performed the first US EVAR and the first EVAR for a ruptured AAA. Dr.Veith has been a leading advocate for the recognition of Vascular Surgery as a separate, distinct specialty. He is now Professor of Surgery at NYU and the Cleveland Clinic and leads the largest Vascular meeting held annually in New York City.

Dr. Roberson graduated from Baylor University, National Merit Scholar and Honors Program. Medical degree at the University of Texas, Southwestern. Resident in Radiology at Baylor Hospital; Dallas, Texas followed by a fellowship in neuroradiology at Mallinckrodt Institute of Radiology and subsequently Director of Neuroradiology. He was instructor of Radiology, Assistant Professor of Radiology and Associate Professor of Radiology at Harvard Medical School and was Chief of Neuroradiology at Massachusetts General. Dr. Roberson was Chair of Radiology, Albany Medical Center in Albany, NY, Medical Director of Computerized Medical Imaging in Sherman Oaks California and Chair of Radiology at Texas Tech University at Lubbock, Texas. Chief of Neuroradiology, UAB 15 years. He has authored or co-authored 105 peer-reviewed articles and 13 book chapters. He completed a master degree in Medical Management at the University of Texas in Dallas in 2000. He served as an oral examiner for the American Board of Radiology.

Dr. Krupinski is a Professor at Emory University in the Department of Radiology & Imaging Sciences where she is Vice-Chair for Research. She received her BA from Cornell, MA from Montclair State and PhD from Temple, all in Experimental Psychology. Her interests are in medical image perception, observer performance, medical decision making, and human factors. She is Associate Director of Evaluation for the Arizona Telemedicine Program and Director of the Southwest Telehealth Resource Center (SWTRC). She has published extensively in these areas, and has presented at conferences nationally and internationally. She is Past Chair of the SPIE Medical Imaging Conference, Past President of the American Telemedicine Association, President of the Medical Image Perception Society, and Past Chair of the Society for Imaging Informatics in Medicine. She serves on editorial boards for both radiology and telemedicine journals and is the Co-Editor of the Journal of Telemedicine & Telecare.

Mallikarjunarao Kasam has completed his PhD from Osmania University, India and postdoctoral studies from UPENN, NYU School of Medicine and from Mayo Clinic Rochester, MN USA. He is the director and Chief Medical Physicist at SMPC LLC, a medical physics consulting service organization. He has published more than 15 papers in reputed journals and has been serving as an editorial board member of reputed journals.

Dr. Mallikarjunarao Kasam research interest includes innovative methodology developments of MRI, MRA, MRV, CT, MRSI, CTP, DTI and fMRI for ischemic stroke, Hemorrhagic stroke and other neurodegenerative diseases/biomarker applications; Volumetric analysis for the regions of ischemic, hematoma and peri-hematomal edema regions in both AIS and ICH strokes; Development of new methodologies for the detection of vasculature abnormalities and for the development of database for NEURO (AIS and ICH), body (PAD and renal arteries) and cardiac applications. Non-invasive estimation of microglia activity through MRI/MRA/MRV in the above pathological tissues;The study of CST damage, and clinical / functional scale correlation etc. after ischemic and hemorrhagic strokes. Mapping of different metabolites for the normal subjects and subjects with Ischemic stroke, Intracerebral Hemorrhage; Developing novel, multinuclear (23Na, 17O, 13C, F19 and 1H) MRI, MRS applications magnetic resonance imaging and spectroscopic techniques for early diagnosis and quantification of physiological and functional parameters in pathologies such as ischemic stroke and ICH stroke.

Haohua Tu received the BS degree during the year 1992 in Engineering from TsingHua University, Beijing, China, and the PhD degree during the year 2001 in Engineering from the University of Kentucky, Lexington. From 2001 to 2005, he was a Postdoctoral Scientist at University of North Carolina, and at University of California-Merced. Since 2005, he has been a Research Scientist and Principal Investigator at the Biophotonics Imaging Laboratory, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana. He has 54 peer-reviewed publications, 41 conference proceedings, and multiple patents in the fields of biomedical optical imaging, photonics device development, optical physics, and chemical engineering.

Michael Goris has a Medical degree from the University of Leuven in Belgium and a PhD degree in Medical Physics from UC Berkeley. He has been a Professor in the Stanford Medical School and is Emeritus since 2012 and served as a Chairman for University panel on Radiation safety during 2003-2010. He has more than 120 publications in peer reviewed, journals. His research interests are Radio-immunotherapy, Medical Imaging Processing and Quantification for diagnosis Clinical validations.

Michael Goris research interest includes radio-immunotherapy, medical imaging processing and Quantification for diagnosis and clinical validations.

Binsheng Zhao received her D.Sc. degree in 1994 from University of Heidelberg, Germany. She is currently a Professor of Radiology (Physics) and Director of Computational Image Analysis Lab in the Department of Radiology, Columbia University Medical Center, New York.

Binsheng Zhao current research interests include computer-aided cancer detection, diagnosis, response prediction and assessment in multiple diseases in oncology as well as imaging harmonization for quantitative image analysis